X-TRAP: Phase I/II Study of Capecitabine Plus Aflibercept in Metastatic Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 08 Nov 2017
Price : $35 *
At a glance
- Drugs Aflibercept (Primary) ; Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms X-TRAP
- 31 Aug 2018 Biomarkers information updated
- 09 Jun 2017 Status changed from active, no longer recruiting to completed.
- 17 Sep 2016 Planned End Date changed from 1 Aug 2017 to 1 Jun 2018.